The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index, and 1 are not checked yet.
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine
Open accessAbstract
Monamines subserve many critical roles in the brain, and monoaminergic drugs such as amphetamine have a long history in the treatment of neuropsychiatric disorders and also as a substance of abuse. The clinical effects of amphetamine are quite variable, from positive effects on mood and cognition in some individuals, to negative responses in others, perhaps related to individual variations in monaminergic function and monoamine system genes. We explored the effect of a functional polymorphism ( val 158 -met ) in the catechol O -methyltransferase gene, which has been shown to modulate prefrontal dopamine in animals and prefrontal cortical function in humans, on the modulatory actions of amphetamine on the prefrontal cortex. Amphetamine enhanced the efficiency of prefrontal cortex function assayed with functional MRI during a working memory task in subjects with the high enzyme activity val / val genotype, who presumably have relatively less prefrontal synaptic dopamine, at all levels of task difficulty. In contrast, in subjects with the low activity met / met genotype who tend to have superior baseline prefrontal function, the drug had no effect on cortical efficiency at low-to-moderate working memory load and caused deterioration at high working memory load. These data illustrate an application of functional neuroimaging in pharmacogenomics and extend basic evidence of an inverted-“U” functional-response curve to increasing dopamine signaling in the prefrontal cortex. Further, individuals with the met / met catechol O -methyltransferase genotype appear to be at increased risk for an adverse response to amphetamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that WM performance in psychotic and healthy subjects rely on dopamine levels within the PFC (Dumontheil et al., 2011; Mattay et al., 2003; Okubo et al., 1997).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some human participants who had lower baseline dopamine levels (due to Val/Val allele in COMT gene), showed improved WM performance after dexamphetamine administration, while others who had a higher dopamine level (met/met allele subjects) showed the opposite effect”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, methionine substitutions in COMT increase the stress response in mice75 and make humans more susceptible to cognitive impairment following stress and psychostimulant medication74.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the methionine substitution in the COMT protein that results from one of the COMT polymorphisms reduces the ability of COMT to catabolize dopamine and increases vulnerability to stress- or stimulant-induced working memory impairments in human subjects74 and in mice75.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citationModulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Allelic discrimination using fluorogenic probes and the 5' nuclease assay.
Livak, K. (1999) · Genetic Analysis, Techniques and Applications (GATA) · doi:10.1016/s1050-3862(98)00019-9 · Cited by 1,352
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Allelic discrimination using fluorogenic probes and the 5' nuclease assay
Foitzi, T. (1999) · Medical Entomology and Zoology · Cited by 783
Callicott, J. H. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.1.20 · Cited by 771
Self-citation
Research works printed but not linked: 1
- P Mannisto, S Kaakkola Pharmacol Rev 51, 593–628 (1999).
Cited by
Sorted by citations
Stress signalling pathways that impair prefrontal cortex structure and function
Arnsten, A. F. T. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2648 · Cited by 3,299
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Self-citationInhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673
The activation of attentional networks
FAN, J., MCCANDLISS, B., FOSSELLA, J., FLOMBAUM, J., & POSNER, M. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.004 · Cited by 1,737
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Self-citationThe principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592
Cuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377
Intermediate phenotypes and genetic mechanisms of psychiatric disorders
Meyer-Lindenberg, A., & Weinberger, D. R. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1993 · Cited by 1,216
Self-citationMechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,243
Discovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013
Explaining the Many Varieties of Working Memory Variation: Dual Mechanisms of Cognitive Control
Braver, T. S., Gray, J. R., & Burgess, G. C. (2008) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195168648.003.0004 · Cited by 886
Cools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903
Bilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300542 · Cited by 769
The correlative triad among aging, dopamine, and cognition: Current status and future prospects
Bäckman, L., Nyberg, L. H., Lindenberger, U., Li, S., & Farde, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.06.005 · Cited by 795
Strategies for stroke rehabilitation
Dobkin, B. H. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00851-8 · Cited by 732
MacDonald, S. W. S., Nyberg, L., & Bäckman, L. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.06.011 · Cited by 664
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.024 · Cited by 699
Self-citationVolkow, N. D., Fowler, J. S., & Wang, G.-J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.019 · Cited by 616
Durstewitz, D., & Seamans, J. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.015 · Cited by 586
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia
Winterer, G., & Weinberger, D. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.002 · Cited by 610
Self-citationMoment-to-moment brain signal variability: A next frontier in human brain mapping?
Garrett, D. D., Samanez-Larkin, G. R., MacDonald, S. W. S., Lindenberger, U., McIntosh, A. R., & Grady, C. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.015 · Cited by 624
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2012) · Neurodegenerative Diseases · doi:10.1159/000341998 · Cited by 574
Keller, M. C., & Miller, G. F. (2006) · Behavioral and Brain Sciences · doi:10.1017/s0140525x06009095 · Cited by 553
Brisch, R., Saniotis, A., Wolf, R. J., Bielau, H., Bernstein, H., Steiner, J. H., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00047 · Cited by 575
The endophenotype concept in psychiatric genetics
FLINT, J., & MUNAFÒ, M. R. (2007) · Psychological Medicine · doi:10.1017/s0033291706008750 · Cited by 477
Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis
Mier, D., Kirsch, P., & Meyer-Lindenberg, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.36 · Cited by 464
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462
Smith, M. E., & Farah, M. J. (2011) · Psychological Bulletin · doi:10.1037/a0023825 · Cited by 456
Bäckman, L., Lindenberger, U., Li, S.-C., & Nyberg, L. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.008 · Cited by 414
Toxicity of amphetamines: an update
Carvalho, M. C., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F. D., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 449
Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype
Meyer-Lindenberg, A., Kohn, P. D., Kolachana, B., Kippenhan, S., McInerney-Leo, A., Nussbaum, R., Weinberger, D. R., & Berman, K. F. (2005) · Nature Neuroscience · doi:10.1038/nn1438 · Cited by 428
Self-citationToward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423
Robbins, T. W. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2097 · Cited by 413
Tunbridge, E. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1124-04.2004 · Cited by 423
Barnett, J. H., Scoriels, L., & Munafò, M. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.005 · Cited by 412
Human aging magnifies genetic effects on executive functioning and working memory
Nagel, I. E. (2008) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.001.2008 · Cited by 415
Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies
Tromp, D., Dufour, A., Lithfous, S., Pebayle, T., & Després, O. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.08.006 · Cited by 390
Estrogen Shapes Dopamine-Dependent Cognitive Processes: Implications for Women's Health
Jacobs, E., & D'Esposito, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6394-10.2011 · Cited by 342
Neurophysiological correlates of age-related changes in working memory capacity
Mattay, V. S., Fera, F. S., Tessitore, A., Hariri, A. R., Berman, K. F., Das, S., Meyer‐Lindenberg, A., Goldberg, T. E., Callicott, J. H., & Weinberger, D. R. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.025 · Cited by 387
Self-citationDrabant, E. M., Hariri, A. R., Meyer‐Lindenberg, A., Muñoz, K. E., Mattay, V. S., Kolachana, B. S., Egan, M. F., & Weinberger, D. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1396 · Cited by 387
Self-citationVariation in dopamine genes influences responsivity of the human reward system
Dreher, J.-C., Kohn, P., Kolachana, B., Weinberger, D. R., & Berman, K. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805517106 · Cited by 376
Self-citationNeural underpinnings of within-person variability in cognitive functioning.
MacDonald, S. W. S., Li, S., & Bäckman, L. (2009) · Psychology and Aging · doi:10.1037/a0017798 · Cited by 387
Dopaminergic Modulation of Arousal in Drosophila
Waldowski, R. A., van Swinderen, B., & Greenspan, R. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.025 · Cited by 359
Role of dopamine in the motivational and cognitive control of behavior
Cools, R. (2008) · The Neuroscientist · doi:10.1177/1073858408317009 · Cited by 352
Applications of fMRI in translational medicine and clinical practice
Matthews, P. M., Honey, G. D., & Bullmore, E. T. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1929 · Cited by 336
The molecular genetics of cognition: dopamine, COMT and BDNF
Savitz, J. B., Solms, M., & Ramesar, R. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00163.x · Cited by 328
Krystal, J. H., Perry, E. B., Gueorguieva, R., Belger, A., Madonick, S. H., Abi-Dargham, A., Cooper, T. B., MacDougall, L., Abi-Saab, W., & D’Souza, D. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.985 · Cited by 317
COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome
Gothelf, D., D, S. E. M., Thompson, T., Hinard, C., Penniman, L. C., Feinstein, C., Kwon, H., Jin, S., Jo, B., Antonarakis, S. E., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1572 · Cited by 318
Impact of complex genetic variation in COMT on human brain function
Meyer‐Lindenberg, A., Nichols, T. E., Callicott, J. H., Ding, J., Kolachana, B. S., Buckholtz, J. W., Mattay, V. S., Egan, M. F., & Weinberger, D. R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001860 · Cited by 326
Self-citationWahlstrom, D., Collins, P., White, T., & Luciana, M. (2010) · Brain and Cognition · doi:10.1016/j.bandc.2009.10.013 · Cited by 311
“Interestingly, COMT activity has been hypothesized to predict an individual’s place on the inverted-U shaped function describing the relationship between dopaminergic signaling and cognitive performance (Goldman-Rakic, 1998; Mattay et al., 2003).”
BackgroundHarrison, P. J., & Tunbridge, E. M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301543 · Cited by 308
Imaging the Addicted Human Brain
Fowler, J. S., Volkow, N. D., Kassed, C. A., & Chang, L. (2007) · Science & Practice Perspectives · doi:10.1151/spp07324 · Cited by 309
Working Memory Capacity Predicts Dopamine Synthesis Capacity in the Human Striatum
Cools, R., Gibbs, S. E., Miyakawa, A., Jagust, W., & D'Esposito, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4475-07.2008 · Cited by 302
Henquet, C., Rosa, A., Krabbendam, L., Papiol, S., Fañanás, L., Drukker, M., Ramaekers, J. G., & van Os, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301197 · Cited by 304
Reversal learning in Parkinson's disease depends on medication status and outcome valence
Cools, R., Altamirano, L. J., & D’Esposito, M. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.03.030 · Cited by 294
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Capela, J. P., Carmo, H., Remião, F., Bastos, M. D. L., Meisel, A., & Carvalho, F. D. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8064-1 · Cited by 294
Attention-Deficit Hyperactivity Disorder (ADHD)
Voeller, K. K. S. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190100901 · Cited by 295
L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease
Cools, R., Lewis, S. J. G., Clark, L., Barker, R. A., & Robbins, T. W. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301153 · Cited by 296
Bertolino, A., Caforio, G., Blasi, G., Candia, M. D., Latorre, V., Petruzzella, V., Altamura, M., Nappi, G., Papa, S., Callicott, J. H., et al. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1798 · Cited by 283
Self-citationNeurobehavioral evidence for changes in dopamine system activity during adolescence
Wahlstrom, D., White, T., & Luciana, M. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.007 · Cited by 277
Genes and the parsing of cognitive processes
Goldberg, T. E., & Weinberger, D. R. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.05.011 · Cited by 356
Self-citationUsing genetic data in cognitive neuroscience: from growing pains to genuine insights
Green, A. E., Munafo, M. R., DeYoung, C. G., Fossella, J., Fan, J., & Gray, J. R. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2461 · Cited by 287
Cools, R., Sheridan, M. A., Jacobs, E. G., & D’Esposito, M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0601-07.2007 · Cited by 289
Straub, R. E., Lipska, B. K., Egan, M. F., Goldberg, T. E., Callicott, J. H., Mayhew, M. B., Vakkalanka, R., Kolachana, B. S., Kleinman, J. E., & Weinberger, D. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001988 · Cited by 275
Self-citationBarnett, J. H., Jones, P. B., Robbins, T. W., & Müller, U. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001973 · Cited by 274
Brennan, A. R., & Arnsten, A. F. T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.007 · Cited by 267
Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm069 · Cited by 266
Self-citationNeuroimaging endophenotypes: Strategies for finding genes influencing brain structure and function
Glahn, D. C., Thompson, P. M., & Blangero, J. (2007) · Human Brain Mapping · doi:10.1002/hbm.20401 · Cited by 266
Chemistry of the adaptive mind
Cools, R., & Robbins, T. W. (2004) · Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2004.1468 · Cited by 257
Under the curve: Critical issues for elucidating D1 receptor function in working memory
Williams, G. V., & Castner, S. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.028 · Cited by 326
Genes, cognition and brain through a COMT lens
Dickinson, D., & Elvevåg, B. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.014 · Cited by 259
Papaleo, F., Crawley, J. N., Song, J., Lipska, B. K., Pickel, J., Weinberger, D. R., & Chen, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2077-08.2008 · Cited by 288
Self-citationAssociation between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. A., & de Wit, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.17 · Cited by 252
Gould, T. J. (2010) · PubMed Central · Cited by 245
Tolcapone improves cognition and cortical information processing in normal human subjects
Apud, J. A., Mattay, V., Chen, J., Kolachana, B. S., Callicott, J. H., Rasetti, R., Alce, G., Iudicello, J. E., Akbar, N., Egan, M. F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301227 · Cited by 242
Self-citationExecutive Function, Neural Circuitry, and Genetic Mechanisms in Schizophrenia
Eisenberg, D. P., & Berman, K. F. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.111 · Cited by 253
Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective
Robbins, T. W., & Cools, R. (2014) · Movement Disorders · doi:10.1002/mds.25853 · Cited by 235
Lakhan, S. E., & Kirchgessner, A. L. (2012) · Brain and Behavior · doi:10.1002/brb3.78 · Cited by 250
Identification of first candidate genes for creativity: A pilot study
Reuter, M., Roth, S., Holve, K., & Hennig, J. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.046 · Cited by 240
Effect of Catechol- O -Methyltransferase val 158 met Genotype on Attentional Control
Blasi, G., Mattay, V. S., Bertolino, A., Elvevåg, B., Callicott, J. H., Das, S., Kolachana, B. S., Egan, M. F., Goldberg, T. E., & Weinberger, D. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0476-05.2005 · Cited by 294
Self-citationNeuromodulation of reward‐based learning and decision making in human aging
Eppinger, B., Hämmerer, D., & Li, S. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06230.x · Cited by 236
Age-related decline in brain resources magnifies genetic effects on cognitive functioning
Lindenberger, U. (2008) · Frontiers in Neuroscience · doi:10.3389/neuro.01.039.2008 · Cited by 233
Understanding Genetic Risk for Aggression: Clues From the Brain’s Response to Social Exclusion
Eisenberger, N. I., Way, B. M., Taylor, S. E., Welch, W. T., & Lieberman, M. D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.007 · Cited by 229
Clatworthy, P. L., Lewis, S. J. G., Brichard, L., Hong, Y. T., Izquierdo, D., Clark, L., Cools, R., Aigbirhio, F. I., Baron, J.-C., Fryer, T. D., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3266-08.2009 · Cited by 229
Chemistry of the mind: Neurochemical modulation of prefrontal cortical function
Robbins, T. W. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20717 · Cited by 292
Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task
Nagano-Saito, A., Leyton, M., Monchi, O., Goldberg, Y. K., He, Y., & Dagher, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3921-07.2008 · Cited by 222
Meyer‐Lindenberg, A., Kolachana, B. S., Gold, B., Olsh, A., Nicodemus, K. K., Mattay, V. S., Dean, M. C., & Weinberger, D. R. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.54 · Cited by 221
Self-citationNolan, K. A., Bilder, R. M., Lachman, H. M., & Volavka, J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.359 · Cited by 226
Etnier (1997) · doi:10.1523/jneurosci.4975-05.2006 · Cited by 219
Self-citationMonte-Silva, K. K., Kuo, M., Thirugnanasambandam, N., Liebetanz, D., Paulus, W., & Nitsche, M. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0728-09.2009 · Cited by 217
Honey, G. D., & Bullmore, E. T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.009 · Cited by 214
Thapar, A., Langley, K., Fowler, T., Rice, F. J., Turic, D., Whittinger, N., Aggleton, J. P., van den Bree, M. B. M., Owen, M. J., & O’Donovan, M. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1275 · Cited by 201
Cools, R., & Arnsten, A. F. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01100-8 · Cited by 216
Pathways to schizophrenia: the impact of environmental factors
Howes, O. D., McDonald, C., Cannon, M. D., Arseneault, L., Boydell, J. E., & Murray, R. M. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004122 · Cited by 208
Cognitive heterogeneity in schizophrenia
Joyce, E. M., & Roiser, J. P. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3280ba4975 · Cited by 198
The treatment of cognitive impairment in schizophrenia
GOFF, D. C., Hill, M. B., & Barch, D. M. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.009 · Cited by 203
de Jongh, R., Bolt, I. L. L. E., Schermer, M., & Olivier, B. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.12.001 · Cited by 198
Metadata
- Authors
- Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-04-25
- Volume
- 100
- Issue
- 10
- Pages
- 6186-6191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC156347
- OpenAlex
- W2123636362
- Cited by
- 893
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 10 · 2020: 19 · 2019: 13 · 2018: 17 · 2017: 30 · 2016: 34 · 2015: 51 · 2014: 50 · 2013: 66 · 2012: 61
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, amphetamine, prefrontal cortex, working memory, dopamine signaling, pharmacogenomics, individual differences, monoaminergic systems
- MeSH terms
- Brain, Catechol O-Methyltransferase, Dextroamphetamine, DNA, Genotype, Humans, Magnetic Resonance Imaging, Methionine, Organ Specificity, Valine, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
